• Product NameGinsenoside F1
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityGinsenoside F1,an enzymatically modified derivative of ginsenoside Rg1, protection from ultraviolet-B-induced apoptosis is tightly correlated with ginsenoside-F1-mediated inhibition of ultraviolet-B-induced downregulation of Bcl-2 and Brn-3a expression. Ginsenoside F1 exhibited competitive inhibition of the activity of CYP3A4 with Ki values of 57.7 9.6 μM and 67.8 16.2 μM, respectively. Ginsenoside F1 exhibited a weaker inhibition of the activity of CYP2D6.
• Target NameP450 inhibitor
• CAS No. 53963-43-2
• Calculated MW 638.88
• Formulation C36H62O9
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Others
  SMILES:CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C
  Pathways:Metabolism
  Receptor:CYP3A4
  Boling pt:
  Melting pt:
  Solubility:Soluble in Pyridine, Methanol, Ethanol, etc.
  Appearance:White powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Kim JH, et al. Exp Dermatol. 2015 Feb;24(2):150-2.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting